MENU

Why these 4 ASX shares have sunk lower today

After a solid start to the day, in afternoon trade the benchmark S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has faded and finds itself down 0.1% to 5,718 points.

Four shares falling more than most today are listed below. Here’s why they have sunk lower:

The Bionomics Ltd (ASX: BNO) share price has tumbled 5% to 46 cents despite there being no news out of the fledgling biotechnology company. But with its shares up over 40% year-to-date I wouldn’t be surprised if today’s decline related to profit-taking. I wouldn’t be in a rush to sell shares if I were a shareholder, I think Bionomics is one of the most exciting biotech shares in Australia.

The CogState Limited (ASX: CGS) share price has fallen over 5% to $1.06 following the release of its full-year guidance. Unfortunately the cognitive science company has had a weaker-than-expected second-half due to delays in the execution of sales contracts. As a result, management expects to post a $1 million loss this year.

The Hydroponics Company Ltd (ASX: THC) share price has plunged 8% to 29 cents even though the diversified cannabis company announced that it has been granted a medicinal cannabis licence. Management believes it is now well placed to lead the development of high quality and cost effective medicines derived from cannabis sativa.

The Reckon Limited (ASX: RKN) share price is down almost 7% to $1.51. This latest gain means the software solutions company’s shares have now fallen close to 12% in the last 30 days. At present Reckon is in the process of demerging its Document Management segment into an independent and UK-listed company by the name of GetBusy Plc.

Finally, if your portfolio took a hit today I would suggest you give it a lift with an investment in one of these stunning growth shares.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.